Cadmium exposure as a putative risk factor for the development of pancreatic cancer: three different lines of evidence

A Buha, D Wallace, V Matovic… - BioMed Research …, 2017 - Wiley Online Library
Although profoundly studied, etiology of pancreatic cancer (PC) is still rather scant.
Exposure to cadmium (Cd), a ubiquitous metal associated with well‐established toxic and …

Environmental risk factors for pancreatic cancer: an update

E Barone, A Corrado, F Gemignani, S Landi - Archives of Toxicology, 2016 - Springer
Pancreatic cancer (PC) is one of the most aggressive diseases. Only 10% of all PC cases
are thought to be due to genetic factors. Here, we analyzed the most recently published case …

Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland

T Soini, R Hurskainen, S Grénman… - Obstetrics & …, 2014 - journals.lww.com
OBJECTIVE: To examine the association between premenopausal use of the levonorgestrel-
releasing intrauterine system and cancer incidence in Finland with a special focus on …

Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981–2010

H Sun, H Ma, G Hong, H Sun, J Wang - Scientific reports, 2014 - nature.com
Pancreatic cancer (PaCa) is an aggressive malignancy with a high mortality rate and a poor
prognosis. To evaluate treatment outcomes of patients with pancreatic cancer over the past …

[HTML][HTML] Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le …

FA Trémollieres, N Chabbert-Buffet, G Plu-Bureau… - Maturitas, 2022 - Elsevier
Aim The aim of these recommendations is to set forth an individualized approach to the
management of early postmenopausal women (ie, within the first 10 years after natural …

Is female health cyclical? Evolutionary perspectives on menstruation

A Alvergne, VH Tabor - Trends in ecology & evolution, 2018 - cell.com
Why do some females menstruate at all? Answering this question has implications for
understanding the tight links between reproductive function and organismal immunity. Here …

[HTML][HTML] Pharmacologic activation of the G protein–coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma

CA Natale, J Li, JR Pitarresi, RJ Norgard… - Cellular and Molecular …, 2020 - Elsevier
Background & Aims Female sex is associated with lower incidence and improved clinical
outcomes for most cancer types including pancreatic ductal adenocarcinoma (PDAC). The …

Chrysin-induced G protein-coupled estrogen receptor activation suppresses pancreatic cancer

HK Lim, HJ Kwon, GS Lee, JH Moon… - International Journal of …, 2022 - mdpi.com
Pancreatic cancer (PC) has a high mortality rate due to its poor prognosis and the possibility
of surgical resection in patients with the disease. Importantly, adjuvant chemotherapy is …

Sex, gender and age differences in treatment allocation and survival of patients with metastatic pancreatic cancer: a nationwide study

EN Pijnappel, M Schuurman, AD Wagner… - Frontiers in …, 2022 - frontiersin.org
Background Biological sex, gender and age have an impact on the incidence and outcome
in patients with metastatic pancreatic cancer. The aim of this study is to investigate whether …

Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women

G Peduzzi, L Archibugi, V Katzke, M Gentiluomo… - Scientific reports, 2022 - nature.com
The incidence of pancreatic ductal adenocarcinoma (PDAC) is different among males and
females. This disparity cannot be fully explained by the difference in terms of exposure to …